- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Localized Histoplasma capsulatum osteomyelitis of the fibula in an immunocompetent teenage boy: a case report
© Huang et al; licensee BioMed Central Ltd. 2013
Received: 10 December 2012
Accepted: 5 March 2013
Published: 11 March 2013
Infection of local bone with Histoplasma capsulatum is rare and difficult to diagnosis, and occurs particularly in immunocompetent subjects, who are more likely to be affected by a wide range of organisms.
An 11-year-old boy presented with localized histoplasmosis osteomyelitis in the left fibula without any evidence of abnormal immunological function or systemic disease. After surgical clearance of the lesion and homologous cancellous bone, the patient was treated orally with voriconazole for 6 months. The patient completely recovered with full function of his left leg during the 5-year follow-up.
Histoplasmosis osteomyelitis can occasionally occur in immunocompetent individuals and can be complete cured by surgical clearance of the lesion and antibiotic treatment.
Histoplasma capsulatum, a thermally dimorphic fungus, is endemic across North and Central America, particularly in the region of the Mississippi river. Exposure to the organism can cause fatal disseminated fungemia in immunocompromised patients, but only results in an asymptomatic infection in most immunocompetent subjects . Although the organism is found worldwide, cases of histoplasmosis are rare in China. In the past several decades, only a few cases have been reported, and infection with H. capsulatum only in bone is rare. In addition, infection with H. capsulatum is often neglected by Chinese physicians when they differentially diagnose opportunistic infections in patients with abnormal immunological functions [2–10].
We diagnosed and treated one patient, who had no sign of abnormal immune function or other chronic disease, but with histoplasmosis osteomyelitis only in the fibula. We followed the patient for 5 years, and he did not have any adverse consequences. We report this case to discuss our experience in the diagnosis and treatment of patients with histoplasmosis osteomyelitis of the bone.
An 11-year-old boy was admitted to our hospital on February 20, 2006. He complained of having swelling and pain of the lateral portion of the lower leg for 1 week, accompanied by local erythema. He had no fever or chills at the time of admission. In general, he was healthy and had no systemic chronic disease, nor a history of injury in the lower extremity. He denied recent travel or drug use. He was a native resident. The patient denied exposure to any infectious patients and any history of infusion.
Physical examination revealed a body temperature of 37°C, blood pressure of 118/78 mmHg, heart rate of 78 beats/min, respiratory rate of 19 breaths/min, and body weight of 46 kg. The patient appeared to be in good nutritional condition. There was no lymphadenopathy or hepatomegaly noted, and findings in his heart and lungs were unremarkable. There was a 2 × 1 cm red skin nodule with mild tenderness in the lateral malleolus near the left ankle of the fibula. The movement of his ankle joint was satisfactory. His arterial pulse was detected on the dorsum of foot, and he was able to move his toe normally.
Laboratory testing indicated a blood white cell count of 8.6 × 109/L, with neutrophils accounting for 58.3% and lymphocytes for 31.6%. The hematocrit was 36.0%. He was negative for anti-human immunodeficiency virus, anti-syphilis, and anti-hepatitis C virus antibodies, anti-hepatitis A virus immunoglobulin, and hepatitis B surface antigen. The concentration of serum alkaline phosphatase was 226 U/L, slightly higher than the cutoff for abnormal values: >140 U/L), and total bilirubin was 0.19 mg/dL, which was lower than the cutoff value of 0.30 mg/dL. The concentrations of plasma electrolytes, creatinine, urea nitrogen, and albumin were within normal ranges.
H. capsulatum infection causes histoplasmosis, which usually occurs in the lungs. The environmental reservoir of H. capsulatum is soil . People acquire H. capsulatum infection usually through the inhalation of conidial forms of the organism present in the environment, such as in soils exposed to chickens. Our case had no obvious source of the infection. He denied a recent history of travel and was living in the countryside in Zhejiang Province, Southeast China, where there are many breeding chickens and ducks in the farmhouses. His father was a chicken farmer and chickens entered his home. He remembered that he used to clean the chicken coop to help his family’s poultry business before he became ill. It is possible that he acquired the H. capsulatum infection from the poultry. Indeed, the prevalence of potential H. capsulatum infection in Southeast China is higher than that in Northwest China .
Infection of immunocompetent subjects with H. capsulatum usually causes either asymptomatic or mild influenza-like illnesses with fever, headache, malaise, cough, and chest pain, which spontaneously disappear within a few days. Infected individuals can carry H. capsulatum for many years. When the patient becomes immunosuppressed he can develop disseminated histoplasmosis that can affect the lungs, central nervous system, liver, spleen, and rheumatologic, ocular, and hematologic systems . However, patients with histoplasmosis in the bone and muscle tissues are extremely rare . There are 25 reported cases of confirmed muscle-bone histoplasmosis. Among them, most patients had disseminated histoplasmosis and there were only six patients who suffered from simple bone histoplasmosis, with a lesion in the distal radius or carpal bones [13–17]. There was only one reported case with lower limb histoplasmosis. A patient with non-Hodgkin's lymphoma also had H. capsulatum infection in the tibia . Therefore, to the best of our knowledge, this is the first report of a localized histoplasmosis osteomyelitis in the fibula in an immunocompetent young boy.
Rather than filling the surgical lesion with bone cement or antibiotic beads as in adult patients, the surgical cavity of the patient was filled with homologous cancellous bone to reconstruct a stable distal tibiofibular syndesmosis and ankle joint. Indeed, radiological images and physical examination have demonstrated that the function and structure of the surgical muscles and bone tissues completely recovered. The patient was able to take part in normal and strenuous exercise, and even soccer. Itraconazole and amphotericin B were listed as the drugs for the treatment of histoplasmosis . Amphotericin B has been accepted as a standard drug for the treatment of patients with severe illness, but it occasionally has severe side-effects. Amphotericin B has been recommended for induction therapy for disseminated histoplasmosis in patients with acquired immunodeficiency syndrome, and either amphotericin B or an oral azole antifungal agent (itraconazole) for maintenance. Conazoles can be used as an alternative for the treatment of disseminated histoplasmosis, and itraconazole may be used for both induction and maintenance treatment . However, according to itraconazole labeling, there is not enough evidence for its use in children. Consequently, we treated the 11-year-old boy with voriconazole, a conazole with clear labeling and guidance for its use in teenagers. The prognosis was very satisfactory, as the follow-up results indicated.
In summary, we report a unique case of localized histoplasmosis osteomyelitis without evidence of immunocompromise. This disease was difficult to diagnose using common radiological examinations. We found that surgical removal of the lesion and local treatment with autologous bone transplantation, together with systemic treatment with antibiotics were effective for the control of infection and functional recovery.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent (in Chinese) is available for review upon requested.
The authors thank Dr. Disheng Yang, Dr. Huimin Tao, and Dr. Zhaoming Ye for their help in the diagnosis and treatment of the patient, and Dr. Linrong Chen and Dr. Jianhong Xu for help in the pathological diagnosis.
- Kauffman CA: Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007, 20: 115-132. 10.1128/CMR.00027-06.View ArticlePubMedPubMed CentralGoogle Scholar
- Ge L, Zhou C, Song Z, Zhang Y, Wang L, Zhong B, Hao F: Primary localized histoplasmosis with lesions restricted to the mouth in a Chinese HIV-negative patient. Int J Infect Dis. 2010, 14 (Suppl 3): e325-e328.View ArticlePubMedGoogle Scholar
- Lai CH, Huang CK, Chin C, Yang YT, Lin HF, Lin HH: Indigenous case of disseminated histoplasmosis, Taiwan. Emerg Infect Dis. 2007, 13 (1): 127-129. 10.3201/eid1301.060857.View ArticlePubMedPubMed CentralGoogle Scholar
- Cao C, Bulmer G, Li J, Liang L, Lin Y, Xu Y, Luo Q: Indigenous case of disseminated histoplasmosis from the Penicillium marneffei endemic area of China. Mycopathologia. 2010, 170 (1): 47-50. 10.1007/s11046-010-9295-4.View ArticlePubMedGoogle Scholar
- Shen G, Chai Y, Zhang GF, Wei HQ, Yue L: Diagnosis and treatment of pulmonary histoplasmoma: report of 3 cases. Zhonghua Yi Xue Za Zhi. 2007, 87 (11): 760-762.PubMedGoogle Scholar
- Liu XY, Chen KL, You Y, Chen WX, Zou P: The differential features of bone marrow morphology of several rare infectious disorders. Zhonghua Nei Ke Za Zhi. 2005, 44 (12): 902-905.PubMedGoogle Scholar
- Tseng TC, Liaw SJ, Hsiao CH, Wang CY, Lee LN, Huang TS, Hsueh PR: Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease. J Clin Microbiol. 2005, 43 (9): 4911-4913. 10.1128/JCM.43.9.4911-4913.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Li X, Li J, Feng GQ, Gui XE, Zeng XC: A primary investigation on disseminated histoplasmosis in Hubei. Zhonghua Liu Xing Bing Xue Za Zhi. 2003, 24 (8): 708-710.PubMedGoogle Scholar
- Zhao B, Xia X, Yin J, Zhang X, Wu E, Shi Y, Tong M, Sun S, Gui X, Zhao Z: Epidemiological investigation of Histoplasma capsulatum infection in China. Chin Med J (Engl). 2001, 114 (7): 743-746.Google Scholar
- Zhao B, Yin J, Xia X: Investigation on the epidemiology of Histoplasma capsulatum infection in Nanjing district. Zhonghua Liu Xing Bing Xue Za Zhi. 1998, 19 (4): 215-217.PubMedGoogle Scholar
- Wheat LJ, Kauffman CA: Histoplasmosis. Infect Dis Clin North Am. 2003, 17 (1): 1-19. 10.1016/S0891-5520(02)00039-9. viiView ArticlePubMedGoogle Scholar
- Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC: Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore). 2007, 86 (3): 162-169. 10.1097/md.0b013e3180679130.View ArticleGoogle Scholar
- Jones RC, Goodwin RA: Histoplasmosis of bone. Am J Med. 1981, 70 (4): 864-866. 10.1016/0002-9343(81)90544-1.View ArticlePubMedGoogle Scholar
- Palmgren BA, Buhr BR: Histoplasmosis of the tibia. Orthopedics. 2005, 28 (1): 67-68.PubMedGoogle Scholar
- Care SB, Lacey SH: Recurrent histoplasmosis of the wrist: a case report. J Hand Surg Am. 1998, 23 (6): 1112-1114. 10.1016/S0363-5023(98)80025-7.View ArticlePubMedGoogle Scholar
- Schasfoort RA, Marck KW, Houtman PM: Histoplasmosis of the wrist. J Hand Surg Br. 1999, 24 (5): 625-627. 10.1054/jhsb.1999.0273.View ArticlePubMedGoogle Scholar
- McCabe MP, Heck RK: Histoplasma osteomyelitis simulating giant-cell tumor of the distal part of the radius: a case report. J Bone Joint Surg Am. 2010, 92 (3): 708-714. 10.2106/JBJS.H.01507.View ArticlePubMedGoogle Scholar
- Abramowicz M: Systemic antifungal drugs. Med Lett Drugs Ther. 1997, 39 (1009): 86-88.Google Scholar
- Drew RH: Pharmacotherapy of disseminated histoplasmosis in patients with AIDS. Ann Pharmacother. 1993, 27 (12): 1510-1518.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/13/132/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.